Case Report
Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report
Table 1
Timeline of hospitalization.
| Hospital day no. | 1 | 2 | 3 | 4 | 5 |
| Hgb (g/dL) | 6.8, 8.3, 7.2, 5.7 | 5.1, 9, 8.3 | 9.3, 9.7, 9.2 | 8.2, 7.8, 9.3 | 9.5 |
| PT (seconds) | 14.1 | 14.6 | 12.6 | | |
| aPTT (seconds) | 27.2 | 21.5 | 21.9 | | |
| INR | 1.3 | 1.3 | 1.1 | | |
| Intervention | 1,800 units of prothrombin complex concentrate, intravenous fluids, and 2 units of packed red blood cells | 2.5 mg conjugated estrogen and 2 units of packed red blood cells | Balloon tamponade and 2 units of packed red blood cells | Endometrial ablation and 1 unit of packed red blood cells | Discharge |
|
|
Hgb: hemoglobin, PT: prothrombin time, aPTT: activated partial thromboplastin time, INR: international normalized ratio.
|